Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Qihan Li and Zhanlong He.
Qihan Li
Connection Strength
0.958
Zhanlong He
  1. Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults. Clin Infect Dis. 2021 12 06; 73(11):e3949-e3955.
    View in: PubMed
    Score: 0.246
  2. Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques. Mol Ther Methods Clin Dev. 2021 Dec 10; 23:108-118.
    View in: PubMed
    Score: 0.241
  3. The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial. Vaccine. 2021 05 12; 39(20):2746-2754.
    View in: PubMed
    Score: 0.235
  4. A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques. Emerg Microbes Infect. 2021 Dec; 10(1):342-355.
    View in: PubMed
    Score: 0.061
  5. Identification of T Cell Epitopes in the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 in Rhesus Macaques. J Immunol. 2021 06 01; 206(11):2527-2535.
    View in: PubMed
    Score: 0.059
  6. Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys. Bioconjug Chem. 2021 05 19; 32(5):1034-1046.
    View in: PubMed
    Score: 0.059
  7. Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression. PLoS Pathog. 2020 11; 16(11):e1008949.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.